Huaren Pharmaceutical Co Ltd (300110) - Total Liabilities
Based on the latest financial reports, Huaren Pharmaceutical Co Ltd (300110) has total liabilities worth CN¥1.86 Billion CNY (≈ $272.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Huaren Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Huaren Pharmaceutical Co Ltd - Total Liabilities Trend (2007–2025)
This chart illustrates how Huaren Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Huaren Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Huaren Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Huaren Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Consolidated Water Co Ltd
NASDAQ:CWCO
|
USA | $31.03 Million |
|
Hunan Huamin Holdings Co Ltd
SHE:300345
|
China | CN¥3.03 Billion |
|
EUROKAI GmbH & Co. KGaA
F:EUK3
|
Germany | €317.79 Million |
|
Nanjing Central Emporium Group Stocks Co Ltd
SHG:600280
|
China | CN¥9.62 Billion |
|
Stenhus Fastigheter I Norden AB
ST:SFAST
|
Sweden | Skr8.96 Billion |
|
Shenzhen Jinxinnong Feed Co Ltd
SHE:002548
|
China | CN¥4.07 Billion |
|
Nanjing Well Pharmaceutical Co Ltd
SHG:603351
|
China | CN¥819.31 Million |
|
LandOcean Energy Services Co
SHE:300157
|
China | CN¥1.83 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Huaren Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Huaren Pharmaceutical Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Huaren Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Huaren Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual total liabilities of Huaren Pharmaceutical Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.79 Billion ≈ $262.36 Million |
-12.72% |
| 2024-12-31 | CN¥2.05 Billion ≈ $300.59 Million |
-14.40% |
| 2023-12-31 | CN¥2.40 Billion ≈ $351.16 Million |
-6.36% |
| 2022-12-31 | CN¥2.56 Billion ≈ $375.01 Million |
-19.87% |
| 2021-12-31 | CN¥3.20 Billion ≈ $467.98 Million |
+194.48% |
| 2020-12-31 | CN¥1.09 Billion ≈ $158.92 Million |
+135.17% |
| 2019-12-31 | CN¥461.81 Million ≈ $67.58 Million |
-48.52% |
| 2018-12-31 | CN¥897.11 Million ≈ $131.28 Million |
-33.00% |
| 2017-12-31 | CN¥1.34 Billion ≈ $195.92 Million |
+11.67% |
| 2016-12-31 | CN¥1.20 Billion ≈ $175.45 Million |
-8.39% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.52 Million |
+14.62% |
| 2014-12-31 | CN¥1.14 Billion ≈ $167.09 Million |
+25.82% |
| 2013-12-31 | CN¥907.56 Million ≈ $132.80 Million |
+103.63% |
| 2012-12-31 | CN¥445.69 Million ≈ $65.22 Million |
+699.10% |
| 2011-12-31 | CN¥55.77 Million ≈ $8.16 Million |
+17.18% |
| 2010-12-31 | CN¥47.60 Million ≈ $6.96 Million |
-85.22% |
| 2009-12-31 | CN¥321.98 Million ≈ $47.12 Million |
+12.46% |
| 2008-12-31 | CN¥286.30 Million ≈ $41.90 Million |
+61.29% |
| 2007-12-31 | CN¥177.50 Million ≈ $25.97 Million |
-- |
About Huaren Pharmaceutical Co Ltd
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therape… Read more